---  
layout: startup_page  
title: "Grey Wolf Therapeutics"  
id: "greywolftherapeutics.com"  
permalink: "/greywolftherapeuticsgreywolftherapeutics.com05232024/"  
website: "https://greywolftherapeutics.com/"  
funding_round: "Series B"  
funding_amount: "$50M"  
investors: "ICG's Life Sciences team, Pfizer Ventures, Andera Partners, Canaan, Earlybird Venture Capital, Oxford Science Enterprises, British Patient Capital"  
about: "Grey Wolf Therapeutics is a clinical-stage biotechnology company developing antigen modulation therapies to treat immune dysfunction in oncology and autoimmunity. Their lead candidate, GRWD5769, is an ERAP1 inhibitor in a Phase 1/2 clinical trial for solid tumors, with a second inhibitor, GRWD0715, targeting autoimmune diseases. The company's unique approach aims to modify antigen presentation to either stimulate or suppress immune responses."  
markets: "Biotechnology, Immuno-oncology, Autoimmune Diseases, Therapeutics, Health Care"  
hq: "Abingdon, Oxfordshire, United Kingdom"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/greywolf-therapeutics"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/greywolf-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/235062-91"  

date_display: "23-May-2024"  
date: "2024-05-23"

# SEO Optimization  
meta_title: "Grey Wolf Therapeutics - Series B Funding ($50M)"  
meta_description: "Grey Wolf Therapeutics, Grey Wolf Therapeutics is a clinical-stage biotechnology company developing antigen modulation therapies to treat immune dysfunction in oncology and a..."  
meta_keywords: "Grey Wolf Therapeutics, Biotechnology, Immuno-oncology, Autoimmune Diseases, Therapeutics, Health Care, Series B funding"  
canonical_url: "https://startup.projectstartups.com/greywolftherapeuticsgreywolftherapeutics.com05232024/"  
---